A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries
Cost Effectiveness Analysis of Tapentadol PR Versus Oxycodone/Naloxone PR in Patients with Musculoskeletal Pain in Spain
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Evaluación y financiación de medicamentos innovadores en España: ¿Dónde estamos y hacia dónde vamos?
Coste-efectividad de la polipíldora CNIC frente a los monocomponentes separados en prevención secundaria cardiovascular en España
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Optimising the management of patients with multiple myeloma in Spain: A measurement of the social return on investment
Impacto económico del uso de patiromer en enfermedad renal crónica o insuficiencia cardíaca para el tratamiento de la hiperpotasemia crónica en España
